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and Human Development, National Institutes of Health, Bethesda, MarylandABSTRACT Cationic cell-penetrating peptides (CPPs) are a promising vehicle for the delivery of macromolecular drugs.
Although many studies have indicated that CPPs enter cells by endocytosis, the mechanisms by which they cross endosomal
membranes remain elusive. On the basis of experiments with liposomes, we propose that CPP escape into the cytosol is based
on leaky fusion (i.e., fusion associated with the permeabilization of membranes) of the bis(monoacylglycero)phosphate (BMP)-
enriched membranes of late endosomes. In our experiments, prototypic CPP HIV-1 TAT peptide did not interact with liposomes
mimicking the outer leaflet of the plasma membrane, but it did induce lipid mixing and membrane leakage as it translocated into
liposomes mimicking the lipid composition of late endosome. Both membrane leakage and lipid mixing depended on the BMP
content and were promoted at acidic pH, which is characteristic of late endosomes. Substitution of BMP with its structural
isomer, phosphatidylglycerol (PG), significantly reduced both leakage of the aqueous probe from liposomes and lipid mixing
between liposomes. Although affinity of binding to TAT was similar for BMP and PG, BMP exhibited a higher tendency to support
the inverted hexagonal phase than PG. Finally, membrane leakage and peptide translocation were both inhibited by inhibitors of
lipid mixing, further substantiating the hypothesis that cationic peptides cross BMP-enriched membranes by inducing leaky
fusion between them.INTRODUCTIONIn recent years, considerable progress has been made in the
design of macromolecular drugs based on peptides, oligonu-
cleotides, and their mimics (1). The intracellular targets for
many of these drugs are located in the cell nucleus and
cytoplasm, necessitating the development of efficient and
safe approaches for delivering macromolecules into specific
cellular compartments. A major barrier for macromolecules
en route to the cytoplasm and nucleus is the lipid bilayer of
the cell plasma membrane, the same barrier that protects
cells from viruses and bacterial toxins. One of the actively
studied approaches for macromolecular delivery is based
on cationic cell-penetrating peptides (CPPs) (2–4). In
this work we explored the membrane interactions of
HIV-1 TAT48-60 (TAT) peptide, a prototypic CPP. The
delivery of functionally active macromolecular cargo to
the cell cytoplasm and nucleus is facilitated by cationic
CPP binding to ubiquitous cell-surface heparan sulfate
proteoglicans (5–7). Inhibitors of clathrin-dependent endo-
cytosis, caveolin/raft-dependent endocytosis, and macropi-
nocytosis strongly impair cationic peptide-dependent
delivery of functionally active proteins and oligonucleotides
into the cell cytosol and nucleus (6,8–11). The relative role
of different endocytic pathways as observed in different
studies apparently depends on the specific CPP, cargo, and
cell types used in each study (12,13). However, to reach
targets in the cytosol and nucleus, CPP-cargo complexes
internalized by any endocytic pathway would have to crossSubmitted May 4, 2010, and accepted for publication August 2, 2010.
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from the endosome. Apparently, endosomal escape is
a limiting factor in endocytosis-dependent delivery of func-
tionally active CPP-cargo conjugates into the cytosol and
nucleus (14,15). Many viruses and toxins also utilize endo-
cytosis to gain access to the cell cytosol and nucleus. Thus,
understanding the mechanism of endosomal escape is of
great practical importance.
In this work we propose a new model for the delivery of
cationic CPPs and conjugated cargo into the cytosol. This
model is based on both the characteristic multivesicular
morphology of late endosomes and the fact that intraluminal
vesicles are highly enriched with bis(monoacylglycero)
phosphate (BMP), an anionic lipid specific to late endo-
somes. We hypothesize that cationic peptides induce leaky
fusion (i.e., fusion associated with membrane permeabiliza-
tion) between intraluminal vesicles, resulting in delivery of
the peptide and cargo molecules into intraluminal vesicles.
Subsequent back-fusion of intraluminal vesicles with the
limiting membrane of late endosomes releases the peptide
and cargo into the cell cytosol. To test this model, we
focused on interactions of TAT peptide with liposomes of
various lipid compositions, including those mimicking lipid
bilayers of plasma membrane and late endosomes. We
report that TAT peptide induces leakage of encapsulated
probes and translocates across BMP-enriched bilayers
mimicking the lipid composition of intraluminal vesicles
of late endosomes, but not across membranes mimicking
lipid composition of plasma membranes. TAT-induced
leakage and translocation are linked to membrane fusion
and inhibited by fusion inhibitors. These results substantiatedoi: 10.1016/j.bpj.2010.08.029
2526 Yang et al.the proposed model of endosomal escape and suggest that
membrane fusion, which is known to be an important stage
of intracellular delivery for membrane-enclosed macromol-
ecules such as viral nucleic acids, may also be involved in
delivery of membrane-free macromolecules.MATERIALS AND METHODS
Materials
N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-phosphatidylethanolamine (NBD-
PE), N-(lisamine Rhodamine B sulfonyl)-phosphatidylethanolamine
(Rh-PE), cholesterol (Chol), sphingomyelin (SM) from porcine brain,
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (PE), phosphatidylinositol
(PI) from soybean, 1,2-dioleoyl-sn-glycero-3-phosphocholine (PC), dio-
leoyl-BMP, and 1,2-dioleoyl-sn-glycero-3-phospho-(10-rac-glycerol) (PG)
were purchased from Avanti Polar Lipids (Alabaster, AL). A recent study
suggested that naturally occurring BMPs have acyl chains in the sn-2(20)
position (16); however, 2,20-diacyl BMP is not readily commercially avail-
able and is unstable due to 2,3-acyl migration (17). Therefore, we used
commercially available sn-1/sn10 of BMP with acyl chains at the sn-3(30)
positions. We also confirmed in a few experiments that we observe similar
levels of lipid mixing and leakage for liposomes with PC/BMP (1:1) lipid
composition using (S,S)-2,20-Bisoleoyl-LBPA (Echelon-Biosciences, Salt
Lake City, UT). 8-Aminonaphthalene-1,3,6-trisulfonic acid, disodium salt
(ANTS), 8-hydroxypyrene-1,3,6-trisulfonic acid, trisodium salt (HPTS),
and p-xylene-bis-pyridinium bromide (DPX) were purchased from Molec-
ular Probes (Invitrogen, Carlsbad, CA). HIV-1 TAT peptide with the
sequence GRKKRRQRRRPPQCwas custom synthesized by SynPep (Dub-
lin, CA) and purified to 95% by high-performance liquid chromatography.Liposome preparation
Large unilamellar vesicles (LUVs) were prepared by extrusion. In brief,
lipids dissolved in benzene/methanol (95:5, vol/vol) were freeze-dried
under high vacuum overnight and the dried lipid powder was hydrated in
an appropriate buffer at room temperature and then vortexed. The resulting
lipid suspension was submitted to 10 successive cycles of freezing and
thawing, and then extruded 10 times through two stacked Nucleopore poly-
carbonate filters of 100 nm pore size (Whatman Inc., Piscataway, NJ) using
a LIPEX extruder (Northern Lipids, Burnaby, Canada) to produce LUVs.
Liposome sizes were measured using dynamic light scattering on an
N4Plus submicron particle size analyzer (Beckman Coulter, Brea, CA).Lipid mixing
TAT peptide-induced lipid mixing was measured by the dequenching of
rhodamine PE (Rh-PE) fluorescence. Unlabeled liposomes of different lipid
composition and liposomes labeled with a self-quenching concentration
(5 mol %) of Rh-PE were prepared in buffers with pH 5.5 (150 mM NaCl,
10mMMES) or pH7.4 (150mMNaCl, 10mMTris). Liposomeswere added
to a cuvette in a ratio of 1:10 of labeled to unlabeled liposomes for a total lipid
concentration of 25mM.Different concentrations of TAT peptidewere added
to induce lipid mixing between liposomes. All experiments were performed
at room temperature. Lipidmixing between liposomes results in a dilution of
Rh-PE and an increase in dye fluorescence due to a relief of self-quenching.
Fluorescence changes induced by TATwere recorded under constant stirring
using a Bowman-2 luminescence spectrometer (Aminco, Rochester, NY)
with lex ¼ 560 nm and lem ¼ 585 nm. At the end of each recording,
complete dequenching of the dye was induced by addition of Triton X-100
(0.1% v/v final concentration). The degree of dye quenching was calculated
as Q(t)¼ 100 (F(t) F0)/(Ftriton F0), where F(t), F0, and Ftriton are fluo-
rescence at time t, before addition of peptide and after addition of TritonBiophysical Journal 99(8) 2525–2533X-100, respectively. The initial rate of lipid mixing was estimated from
the initial slope of the Q(t) curve. These experiments were carried out in
disposable methacrylate 10 mm pathlength cuvettes in 2 mL of buffer under
constant stirring with a magnetic stirrer bar.
Release of small water-soluble dye
To measure content release, liposomes were prepared in a buffer containing
small water-soluble fluorescent ANTS together with a quencher DPX
(12.5 mM ANTS, 45 mM DPX, 65 mM NaCl, and 10 mM HEPES for
pH 7.4 or 10 mM MES for pH 5.5) or HPTS with DPX (1 mM HPTS,
5 mM DPX, 130 mM NaCl, and 10 mM HEPES for pH 7.4 or 10 mM
MES for pH 5.5). After extrusion, unencapsulated dye and a quencher
were removed by size exclusion chromatography using a PD-10 desalting
column (Amersham Biosciences, Piscataway, NJ). Fluorescence changes
induced by different concentrations of TAT were recorded under constant
stirring using a Bowman-2 luminescence spectrometer (Aminco, Rochester,
NY) with lex¼ 353 nm and lem¼ 520 nm for ANTS and lex¼ 416.4 nm
and lem¼ 520 nm for HPTS. The extent of content leakage was calculated
according to the following equation: % Leakage ¼ 100  (F(t)  F0) /
(Ftriton  F0), where F(t), F0, and Ftriton are fluorescence intensities at
time t, before addition of peptide and after the complete release of encap-
sulated dye by addition of 0.1% v/v of Triton X-100. These experiments
were carried out in disposable methacrylate 10 mm pathlength cuvettes
in 2 mL of buffer under constant stirring with a magnetic stirrer bar.TAT peptide translocation into liposomes
Our assay for TAT translocation is based on the observation that binding of
TAT-fluorescein to vesicles containing anionic lipids results in significant
quenching of the fluorescein signal that then gradually recovers as we
add more liposomes. Similar behavior was observed upon binding of
TAT-fluorescein to the anionic polymer dextran sulfate. This could be
explained by peptide crowding on the liposome surface or on the anionic
polymer that leads to fluorescein self-quenching. Dye self-quenching was
then released as we provided additional binding sites by adding more lipo-
somes or dextran sulfate, and the peptide was diluted on the surface of the
liposomes or polymer. Because binding of TAT to dextran sulfate is signif-
icantly stronger than binding to anionic liposomes (18,19), the addition of
dextran sulfate to a mixture of BMP-containing liposomes and TAT peptide
resulted in a fast inhibition of lipid mixing, content leakage, and reversal of
liposome aggregation (see Fig. S1 in the Supporting Material). To measure
TAT peptide translocation, we first added TAT-fluorescein (2 mM final
concentration) to the buffer, followed by addition of liposomes up to
a 25 mM final concentration. Binding of the peptide to the liposome surface
resulted in a rapid partial quenching of peptide fluorescence. Slow addi-
tional quenching after this rapid initial fluorescence quenching indicated
peptide translocation into the liposomes and binding to the inner monolayer
of the liposome membrane. Then, at different times after addition of the
liposomes, we added a high concentration of 500 kDa dextran sulfate
(20 mM final concentration) to the cuvette. Competitive release of the
TAT peptide from the outer surface of the liposomes and its binding to
the dextran sulfate resulted in a partial recovery of fluorescence. Finally,
we added Triton X-100 to solubilize liposomes and release translocated
peptide from the inner monolayer of liposomes. This resulted in an addi-
tional increase in fluorescence that was used to measure peptide transloca-
tion. These experiments were carried out in disposable methacrylate 10 mm
pathlength cuvettes in 2 mL of buffer under constant stirring with
a magnetic stirrer bar.Liposome aggregation
TAT-induced aggregation of liposomes was measured as an increase in the
absorbance at 440 nm with the use of a DU-8 spectrophotometer (Beckman,
Palo Alto, CA).
FIGURE 1 TAT peptide releases the encapsulated probe from ILM and
LEM liposomes, but not from CPM liposomes. (a and b) Kinetics of dye
dequenching due to the release of ANTS/DPX from 25 mM liposomes of
ILM, LEM, and PM lipid composition upon addition of 2 mM TAT peptide
at pH 5.5 (a) and pH 7.4 (b). (c and d) Dependence of dye dequenching,
measured 50 min after the addition of TAT, on peptide concentration.
Peptide was added to 25 mM of ILM (circles), LEM (triangles), and PM
(squares) liposomes at pH 5.5 (c) and at pH 7.4 (d). Each data point in
panels c and d represents the mean of four independent experiments, and
error bars indicate the standard deviation (SD).
CPP Induces Leaky Fusion of BMP-Containing Membranes 2527TAT-membrane binding
Fluorescein-tagged TAT (F-TAT) was incubated with multilamellar vesicles
(MLVs) at different lipid/peptide molar ratios in Tris or MES buffer
for 30 min at room temperature. The mixtures were then centrifuged at
14,000 rpm for 30 min to pellet MLVs with bound peptide. The supernatants
were incubated with trypsin in Tris buffer for 30 min at 37C to minimize
a loss of fluorescence due to the binding of the peptide to polystyrene. The
fluorescence intensity of the trypsin-treated supernatants was recorded at
520 nm (excitation at 480 nm) to determine the concentration of the free
F-TAT. The concentration of the bound peptide was calculated from the
difference between total amount of the peptide in the mixtures and free
peptide found in the supernatants. We determined the apparent dissociation
constantKd by measuring the fraction of bound peptide, [P]b/[P]tot as a func-
tion of lipid concentration [L]. [P]b is the amount of bound peptide and [P]tot
is the total peptide concentration. The data were fitted by the equation [Pb]/
[Ptot]¼ [L]/(Kdþ [L]). To estimate the fraction of the lipid inMLVs available
for binding, we compared the fluorescence signal of the membrane-imper-
meable lipid dye FM4-64 in the presence of MLVs and in the presence of
LUVs. Fluorescence of FM4-64 dramatically increased upon its membrane
insertion, and thus the changes in FM4-64 fluorescence for the same amount
of the probe give a measure of the total bilayer area accessible for the probe
insertion. For the same total lipid amount, the signal in the presence ofMLVs
was ~10 times smaller than for LUVs, indicating that only 5% of the total
lipid in MLVs was available for FM4-64 and hence TAT binding (assuming
that only half of the total lipids are accessible for binding in LUVs).
Effective molecular shape of DOBMP and DOPG
lipids
To estimate the effective molecular shape of DOBMP and DOPG, we evalu-
ated the effects of adding of small amounts of these lipids to egg PE on the
temperature of the La–HII phase transition. We detected the La–HII phase
transition using changes in NBD-PE fluorescence as described previously
(20). In short, egg PE liposomes containing 0.1 mol % NBD-PE and 0, 5, or
10 mol % of either DOBMP or DOPG were prepared in basic buffer with
pH10 (5mMsodiumborate, 150mMNaCl). The liposome suspensions incu-
bated at different temperatures were acidified to pH 5.5 to induce liposome
aggregation and, at elevated temperatures, the La–HII phase transition. The
phase transition results in an increase in the NBD fluorescence. The depen-
dence of the initial rate of change inNBD-PEfluorescence on the temperature
was used to measure the temperature of the La–HII phase transition.
Escape of fluorescein-tagged dextran
PC or ILM liposomes labeled with 1 mol % Rh-PEwere prepared in a buffer
containing fluorescein-tagged dextran (5 mg/mL FD-70, 130 mM NaCl, 10
mM HEPES). We removed dextran that was not encapsulated into extruded
liposomes by centrifugation on a Ficoll step gradient (0.75 ml 20% Ficoll,
1.5 mL 10% Ficoll, 0.5 mL buffer) for 1 h at 32,500 rpm using an SW-55
Ti rotor. Purified liposomes were collected from the interface between 10%
Ficoll and buffer. Liposomes (500 mM) were incubated with TAT (40 mM)
for 30 min and the released dextran was again removed on a Ficoll step
gradient. The amount of dextran retained in liposomes was measured using
fluorescein fluorescence (lex¼ 495 nm, lem¼ 520 nm) and normalized to
a liposome concentration that was measured using rhodamine fluorescence
(lex ¼ 560 nm, lem ¼ 585 nm).
RESULTS
TAT peptide induces leakage of water-soluble
probes from BMP-enriched liposomes
Because endosomal escape involves an increase in the
permeability of the endosomal membrane for the peptideand conjugated cargo, we first tested whether TAT peptide
induces leakage of a liposome-encapsulated, water-soluble
probe comparable in size to a free peptide (~500 Da for
ANTS versus ~1700 Da for TAT). We compared the effects
of TAT addition to liposomes of different lipid compositions
as follows: 1), a BMP/PC/PE (77:19:4) (ILM) mixture
mimicking the phospholipid composition of intraluminal
vesicles of late endosomes (16); 2), a PC/PE/PI/BMP
(5:2:1:2) (LEM) mixture mimicking the overall phospho-
lipid composition of late endosomes (16); and 3) a PC/PE/
SM/Chol (1:1:1:1.5) (PM) mixture mimicking the lipid
composition of the outer leaflet of the plasma membrane.
The addition of TAT peptide to liposomes of ILM composi-
tion resulted in an efficient escape of liposome-encapsulated
fluorescent probe ANTS both at acidic pH 5.5 characteristic
of late endosomes (ILM; Fig. 1 a,) and, somewhat less effi-
ciently, in neutral pH buffer (pH 7.4, ILM; Fig. 1 b). When
TAT peptide was added to liposomes of LEM composition,
we observed much less efficient dye leakage at pH 5.5 and
almost no leakage in neutral pH buffer (pH 7.4; Fig. 1).
No measurable leakage was observed when TAT peptide
was added to PM liposomes at both neutral and acidic pH
(PM; Fig. 1). The final extent of TAT-induced dye leakage
increased with the peptide concentration at both pH 5.5
and pH 7.4 (Fig. 1, c and d). We observed similar results
when ANTS was replaced with HPTS, another small
water-soluble fluorescent probe (Fig. S2 A). To test whetherBiophysical Journal 99(8) 2525–2533
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somes, we prepared ILM and PM liposomes encapsulating
fluorescein-labeled 70 kDa dextran. Although TAT induced
release of dextran from ILM liposomes, we did not observe
release of dextran from PM liposomes (Fig. S2 B).
In brief, TAT permeabilizes liposomes mimicking the
composition of late endosomal membranes, but not those
mimicking the composition of the outer leaflet of the plasma
membrane. The TAT-induced pores are large enough to
allow the release of large macromolecules.TAT peptide induces fusion between liposomes
with high content of BMP
Because the addition of TAT peptide to ILM and LEM lipo-
somes induced their aggregation (Fig. S2 C), we tested
whether TAT induces lipid mixing between liposomes.
The efficiency of lipid mixing was quantified as the initial
rate of dequenching of the lipid dye Rh-PE upon addition
of different concentrations of TAT peptide to labeled
(5 mol % of Rh-PE) and unlabeled liposomes mixed in
a 1:10 ratio (Fig. 2). The addition of TAT peptide to ILM
liposomes led to efficient lipid mixing at both acidic
pH 5.5 (Fig. 2, a and c, ILM and solid circles) and neutral
pH 7.4 (Fig. 2, b and d, ILM and open circles). When
TAT peptide was added to LEM liposomes, lipid mixing
was observed in both acidic and neutral pH buffers, although
it was less efficient than lipid mixing between ILM
liposomes (Fig. 2, LEM and triangles). In contrast, no lipidFIGURE 2 TAT induces lipid mixing for ILM and LEM liposomes, but
not for CPM liposomes. (a and b) Kinetics of Rh-PE dequenching due to
lipid mixing between ILM, LEM, and PM liposomes induced by 1 mM
TAT at pH 5.5 (a) and pH 7.4 (b). (c and d) Dependence of the initial
rate of lipid mixing induced by TAT on peptide concentration. TAT was
added to 25 mM of a 1:9 mixture of labeled and unlabelled liposomes
with ILM (circles), LEM (triangles), and PM (squares) lipid composition
at pH 5.5 (c) and at pH 7.4 (d).Each data point in panels c and d represents
the mean of four independent experiments, and error bars indicate the SD.
Biophysical Journal 99(8) 2525–2533mixing was observed upon addition of TAT peptide to PM
liposomes (Fig. 2, PM and squares). The efficiency of lipid
mixing was dependent on peptide concentration for both
ILM and LEM lipid compositions.
Leakage of liposome content in the presence of TAT
precluded us from using a liposome content mixing assay
to further confirm that TAT merges liposomal bilayers.
Furthermore, significant aggregation of ILM and LEM lipo-
somes in the presence of TAT would prevent detection of
liposome fusion by liposome size measurements. However,
we were able to reverse liposome aggregation by addition of
dextran sulfate (Fig. S1 C), which binds TAT peptide signif-
icantly more strongly than anionic liposomes (18,19). Addi-
tion of dextran sulfate to a mixture of ILM liposomes and
TAT peptide also resulted in a rapid inhibition of content
leakage and lipid mixing, and reversal of liposome aggrega-
tion (Fig. S1, A and B). Thus, the addition of dextran sulfate
at the end of the lipid mixing experiment allowed us to
compare liposome sizes before and after incubation of lipo-
somes with TAT peptide. Using dynamic light scattering, we
measured ILM liposome sizes before and after 30 min incu-
bation with TAT peptide to be 111 nm and 142 nm, respec-
tively, with the polydispersity index of liposome distribution
increasing from 0.092 to 0.148. These results, along with the
lipid mixing data, indicate that TAT fuses ILM liposomes.Leakage and lipid mixing depend on BMP content
To explore the role of BMP in TAT-induced liposome leakage
and lipid mixing, we prepared liposomes from a set of
PC/BMP mixtures with mole fractions of BMP varied from
0 to 60%. As we increased the mole fraction of BMP in the
mixture, the efficiency of both dye leakage (Fig. 3, a and b)
and lipidmixing (Fig. 3, c and d) increased. For all BMP-con-
taining liposomes, leakage and lipid mixing at pH 5.5 were
more efficient than at pH 7.4 (Fig. 3, b and d).
Although BMP is a predominant anionic lipid in late
endosomes, we were interested in determining whether it
can be replaced with another anionic lipid in vitro. The
replacement of BMP in a PC/BMP (1:1) mixture with its
structural isomer, PG, resulted in a significant inhibition
of TAT-induced lipid mixing and aqueous probe leakage
(Fig. 4). Similarly, replacement of BMP in the ILM mixture
with PG resulted in a strong inhibition of dye leakage
(Fig. S3). This inhibition cannot be explained by differences
in TAT peptide binding because TAT peptide bound
similarly to BMP- and PG-containing liposomes (Fig. S4),
and induced a similar degree of liposome aggregation for
BMP- and PG-containing liposomes (Fig. S5).TAT peptide translocates across membranes
with high content of BMP
Although our membrane leakage experiments indicated that
TAT-induced pores in BMP-enriched membranes are large
FIGURE 3 Efficiencies of TAT-induced aqueous probe leakage (a and b)
and lipid mixing (c and d) rise with an increase in the mole fraction of BMP
in liposomes. (a) The time course of encapsulated ANTS/DPX release from
liposomes composed of different BMP/PC mixtures (25 mM total lipid
concentration) induced by 2 mMTATat pH 5.5. Mol % of BMP in each lipid
composition is indicated on the figure. (b) Dependence of dye dequenching
measured 50 min after addition of 2 mM TAT to 25 mM liposomes on the
mole fraction of BMP in binary BMP/PCmixtures at pH 5.5 (solid symbols)
or at pH 7.4 (open symbols). (c) Dependence of the initial rate of lipid mix-
ing induced by TAT on the mole fraction of BMP in binary BMP/PC
mixtures at pH 5.5 (the mol % of BMP is indicated in the figure). TAT
was added to 25 mM of 1:9 mixtures of labeled and unlabeled liposomes.
(d) Dependence of the initial rate of lipid mixing on mol% of BMP in
BMP: PC binary mixtures at pH 5.5 (solid symbols) or at pH 7.4 (open
symbols). TAT and total lipid concentration was 1 mM and 25 mM, respec-
tively. Each data point on panels (b-d) represents the mean of three indepen-
dent experiments and error bars indicate the standard deviation.
FIGURE 4 Replacement of BMP with structural isomer PG lowers the
efficiencies of aqueous dye leakage and lipid mixing. (a) Dependence of
ANTS/DPX release from liposomes composed of BMP/PC (1:1) (circles)
or PG/PC (1:1) mixtures (triangles) at pH 5.5 (solid symbols) and pH 7.4
(open symbols) on TAT concentration. (b) Dependence of the initial rate
of lipid mixing of BMP/PC (1:1) (circles) or PG/PC (1:1) (triangles)
liposomes at pH 5.5 (solid symbols) and pH 7.4 (open symbols) on TAT
concentration. The total lipid concentration was 25 mM in all experiments.
Each data point represents the mean of three independent experiments, and
error bars indicate the SD.
FIGURE 5 TAT peptide translocates into liposomes that mimic the phos-
pholipid composition of intraluminal vesicles of late endosomes (ILM). (a)
Change in the fluorescence of fluorescein-tagged TAT (2 mM) at pH 5.5
after the addition of 25 mM of ILM (solid line) and PG/PC/PE (77:19:4)
(dotted line) liposomes (þliposomes), 20 mM dextran sulfate (þDS), and
finally 0.1% Triton X-100 (þTriton). (b) Amount of translocated TAT-fluo-
rescein as a function of incubation timewith ILM liposomes. The amount of
translocated peptide was assayed as an increase in fluorescence after the
final addition of Triton X-100 (denoted as DF in panel a).
CPP Induces Leaky Fusion of BMP-Containing Membranes 2529enough to allow passage of aqueous probes comparable in
size or even larger than TAT, we decided to directly verify
that under these conditions TAT peptide itself crosses the
liposomal membrane. To address this question, we used
F-TAT peptide and took advantage of fluorescence quench-
ing upon peptide binding to liposomes containing negatively
charged lipids. After addition of negatively charged
liposomes (25 mM final concentration) to F-TAT (2 mM final
concentration) in a low pH buffer, we observed almost
immediate fluorescence quenching, reflecting binding of
the peptide to the outer monolayer of liposomes (Fig. 5 a,
þliposomes). This fast initial quenching was followed by
a more gradual decrease in fluorescence with a time constant
of ~100 s in the case of ILM liposomes, but not when BMP
in liposome lipid composition was replaced with PG
(Fig. 5 a, þliposomes). The addition of membrane-imper-
meable 500 kDa dextran sulfate (20 mM), which binds the
peptide with a higher affinity than the liposomes (18,19),
released the peptide from the outer surface of the liposomes
and partially dequenched the fluorescence (Fig. 5 a, þDS).
Because dextran sulfate rapidly stops liposome contentleakage (Fig. S1 a), TAT peptide molecules that entered
the inner volume of the liposomes were inaccessible for
dextran sulfate, and thus remained bound to the inner mono-
layer of liposomes and quenched. These TAT peptide
molecules were released from the internal volume of the
liposomes upon addition of Triton X-100 at the end of the
experiment. This release of the peptide resulted in a further
fluorescence increase and gave us a measure of the amount
of peptide that translocated into liposomes (Fig. 5 a,
þTriton, DF). The amount of translocated peptide increased
with the time between the addition of liposomes and the
addition of dextran sulfate (Fig. 5 b). Of interest, the peptide
inside liposomes remained entrapped (Fig. S6) even after
extended incubation with dextran sulfate, suggesting that
TAT-induced leakage of liposome content and peptide trans-
location require interliposome interactions.Biophysical Journal 99(8) 2525–2533
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TAT-induced dye leakage and TAT translocation
To test whether TAT peptide-induced vesicle fusion and
leakage are mechanistically coupled, we modified liposome
composition in two different ways known to inhibit
membrane fusion. In the first approach, we included
2 mol % of PEG-PE in our lipid composition. This lipid
was previously shown to inhibit vesicle fusion by sterically
hindering close opposition of fusing bilayers (21–23). In
the second approach, we modified the lipid composition of
our liposomes by including 20 mol % of LPC. LPC inhibits
diverse fusion processes (24,25), presumably because its in-
verted-cone molecular shape does not match the curvature of
the early-fusion intermediate stalk. In contrast, LPC fits into
the edge of the lipid pore and therefore promotes formation of
lipid pores in membranes (25), and thus is expected to
promote dye leakage. In our experiments, both PEG-PE
and LPC efficiently inhibited both lipid mixing (Fig. 6 b)
and dye leakage (Fig. 6 a). This indicates that leakage and
fusion induced by TAT peptide are mechanistically con-
nected. TAT peptide translocation was also inhibited by
incorporation of 2 mol % of PEG-PE into the ILM liposomes
(Fig. S7).
Membrane fusion involves bending of lipid bilayers, and
the propensity of membranes to fuse correlates with theFIGURE 6 Incorporation of PEG-PE or LPC into the liposome lipid
composition inhibits TAT-induced dye leakage and lipid mixing. The lipo-
some lipid composition was modified by replacing corresponding amounts
of PC in 1), basal BMP/PC (1:1); 2), a lipid mixture with 2 mol % of
PEG-PE; or 3), 20 mol % of LPC. Effects of PEG-PE and LPC incorpora-
tion on the kinetics of dye dequenching due to release of ANTS/DPX from
liposomes (a), the kinetics of Rh-PE dequenching due to lipid mixing
between liposomes (b), the extent of dye dequenching measured 50 min
after addition of the TAT peptide (c), and the initial rate of lipid mixing
(d) are shown. The concentration of TAT was 2 mM and the total lipid
concentration was 25 mM. These experiments were performed in pH 5.5
buffer. Each data point in panels c and d represents the mean of three inde-
pendent experiments, and error bars indicate the SD.
Biophysical Journal 99(8) 2525–2533effective shape of the lipids that constitute the bilayers
(26,27). Similarly, the effective molecular shapes of lipids
strongly affect the propensity of these lipids to form
different phases. In particular, lipids that are cylindrical in
shape (for example, PC) favor the formation of lamellar
La phase, whereas cone-shaped lipids, such as PE, promote
the formation of inverted hexagonal HII phase. Thus, one
can evaluate the effective molecular shapes of lipids by
assessing the effect of minor additions of these lipids on
the temperature of the well-characterized La–phase transi-
tion of PE (20,28–30). We compared the effective molecular
shapes of two lipids (BMP and PG) that have distinct effects
on TAT-induced leakage and lipid mixing. We found that
BMP increased the La–HII transition temperature of egg
PE much less compared to PG (Fig. S8), indicating that
the molecular shape of BMP is more cone-shaped than the
almost cylindrical PG (31). Because cone-shaped lipids
(lipids of negative spontaneous curvature) promote early
fusion stages (25), inhibition of TAT-induced leakage
upon substitution of BMP with PG further substantiates
the key role of fusion in TAT-induced dye escape.
To summarize our data, TAT-induced permeabilization of
BMP-enriched bilayers detected as a release of aqueous
probes from liposomes and entry of TAT peptide into lipo-
somes is mechanistically linked to liposome fusion, indi-
cating that the peptide crosses BMP-containing bilayers
by leaky fusion.DISCUSSION
The mechanism of cationic CPP-mediated delivery into the
cytosol and nucleus remains hotly debated. Although
several groups have reported that at higher peptide concen-
trations (>10 mM) cationic CPPs can directly cross the
plasma membrane (32–36), there is ample experimental
evidence that endocytosis is a necessary step in delivery
of CPP-conjugated cargo into cytosol (for review, see
Edenhofer (37)). In both cases, CPPs have to cross the lipid
bilayer; however, their interactions with endosomal (espe-
cially late endosomal) and plasma membrane may differ
significantly because these membranes are exposed to envi-
ronments with different pH values (pH 5.5–6.0 in endo-
somes versus pH 7.4 at plasma membrane) and have
significantly different lipid compositions. Indeed, the trans-
membrane pH gradient has been suggested to play an impor-
tant role in endosomal escape of pAntp and bPrPp peptides
(38). Although extensive studies on the interactions of
cationic CPPs with protein-free liposomes of different
compositions have led to the proposal of several different
mechanisms of translocation across the lipid bilayer
(39–43), the possible role of differences between the lipid
composition of endosomal and plasma membranes in the
mechanism of CPP translocation has not previously been
explored. Therefore, in this work we investigated whether
the lipid composition of endosomal membranes plays an
CPP Induces Leaky Fusion of BMP-Containing Membranes 2531important role in the mechanism by which cationic peptides
enter cytosol.
Given the cationic nature of most CPPs, we were espe-
cially intrigued by the fact that intraluminal vesicles of late
endosomes are highly enriched with a specific anionic lipid,
BMP (16,44). This is in stark contrast to the outer leaflet of
the plasma membrane, which normally contains a very small
amount of negatively charged lipids, although the cell surface
is negatively charged due to the presence of various proteo-
glycans, including heparan sulfate, which is responsible for
TAT peptide binding (5–7). It was previously shown that
TAT peptide efficiently binds to negatively charged lipo-
somes,whereas binding to uncharged liposomes is very small
(18). Our experiments revealed that TAT peptide binds
strongly to BMP-enriched liposomes, fuses them, releases
liposome-encapsulated aqueous probes, and translocates
into the inner volume of the liposomes. None of these effects
were observed upon addition of TAT peptide to PM lipo-
somes. The promotion of liposome content leakage, fusion,
and peptide translocation at pH 5.5, which is characteristic
of late endosomes, further supports the relevance of the
observed effects for endosomal escape of peptide, although
the mechanism of pH dependence remains unclear. Similar
specificity toward endosomal membranes was recently
reported for octa-arginine-modified liposomes that fused
with endosomes but not with the plasma membrane (45).
Are TAT translocation, lipid mixing, and release of
aqueous probes for lipid bilayers enriched in BMP mecha-
nistically coupled? One may hypothesize that TAT translo-
cates directly through the lipid bilayer, and liposome
leakage and lipid mixing are both unrelated to translocation.
The finding that several modifications of our experimental
system inhibited all of these effects of TAT in concert rather
than uncoupled them argues against this hypothesis.
Replacement of BMP with PG inhibited lipid mixing,
leakage, and TAT translocation. Furthermore, the incorpora-
tion into the lipid bilayer of fusion inhibitor PEG-PE
inhibited not only lipid mixing but also leakage and TAT
translocation. Finally, TAT peptide that entered liposomes
remained entrapped after liposome leakage and lipid mixing
were stopped by addition of dextran sulfate.
Furthermore, our data suggest a mechanistic link between
leakage and lipid mixing induced by TAT. Both of the inhib-
itors of lipid mixing used in our work (PEG-PE and LPC)
also inhibited the escape of encapsulated dye. This is espe-
cially instructive in the case of inverted cone-shaped LPC
because although LPC is a fusion inhibitor, it promotes lipid
pore formation (46) and would be expected to promote
fusion-independent dye leakage. Moreover, inhibition of
both lipid mixing and leakage by replacement of fusion-
promoting, cone-shaped BMP with cylindrical PG also
indicates that lipid mixing and leakage are mechanistically
linked. Note that we do not suggest that leakage and fusion
events induced by TAT occur simultaneously. This is
unlikely, because lipid mixing appears to be more efficientthan leakage, and for some lipid compositions we observed
significant lipid mixing with no leakage. Rather, we suggest
that leakage and fusion share a common intermediate—
possibly the stalk-like intermediate that is involved in
diverse fusion reactions. It is important to note that late
endosomes are not only enriched with BMP and have acidic
pH, they also have a multivesicular morphology that permits
a fusion-dependent mechanism of leakage and translocation
that is unlikely to occur on the plasma membrane or in early
endosomes.
The release of encapsulated dye coincidentally with
membrane fusion was previously observed for a number of
fusion systems (47-49), but was often considered to be
a side effect of biologically relevant, nonleaky fusion reac-
tions (47). Although concomitant leakage is arguably
undesirable in many biological fusion reactions (e.g., exocy-
tosis), we propose that it is instrumental for drug delivery by
cationic peptides. Given that the surface glycoproteins of
some nonenveloped viruses have structural similarities to
proteins that mediate fusion of enveloped viruses (50), it is
tempting to suggest that these nonenveloped viruses employ
similar leaky fusion-dependent mechanisms for endosomal
escape and infection. What could be the mechanism of leaky
fusion? Positive lateral tension generated along the rim of the
expanding stalk facilitates nucleation of the pores in the
vicinity of the rim (48,51). Expansion of the pores that
develop within hemifusion structures results in fusion
without leakage. We speculate that once TAT peptide brings
membranes into close contact, the formation ofmultiple stalk
intermediates within an extended contact zone brings about
lipid mixing and promotes the formation of lipid pores
outside hemifusion structures, allowing dye release and
peptide translocation. Within this scenario, leakage and
fusion are mechanistically connected through a common
intermediate stalk, but do not necessary proceed simulta-
neously or with comparable efficiency. The replacement of
BMP with the less fusogenic lipid PG increases the energy
of the stalk intermediate and consequently inhibits both lipid
mixing and leakage. TAT peptides may lower the energy of
the stalk intermediate and/or just facilitate close opposition
of interacting membranes.
On the basis of our results, we propose the following
model of intracellular entry for cationic CPP-mediated
delivery of conjugated cargo: CPPs bound to heparan
sulfates on the plasma membrane are internalized through
diverse pathways of endocytosis. The low content of anionic
phospholipids in the leaflets of the plasma membrane and
early endosomes that are exposed to CPPs minimizes
peptide interactions with the lipid bilayers of these
membranes. However, once CPPs reach the lumen of a mul-
tivesicular late endosome, they bind to BMP-enriched intra-
luminal vesicles. CPP-mediated leaky fusion between these
vesicles allows the peptide to enter into the lumen of intra-
luminal vesicles. CPP-induced leaky fusion between intralu-
minal vesicles and the limiting membrane is less likely toBiophysical Journal 99(8) 2525–2533
2532 Yang et al.occur because of a relatively low BMP content in the
limiting membrane and a strong dependence of leakage effi-
ciency on BMP. Finally, the BMP-dependent back-fusion of
intraluminal vesicles with limiting membrane that may
proceed independently of CPP (52) releases CPP and
CPP-associated cargo into the cytosol.
Although our results demonstrate a leaky fusion mecha-
nism of CPP escape for protein-free membranes, it remains
to be tested whether this mechanism underlies CPP entry
into the cell cytosol. Given that only a small fraction of
internalized CPP/CPP-cargo conjugate escapes into the
cytosol, this may prove to be a challenging task.SUPPORTING MATERIAL
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